메뉴 건너뛰기




Volumn 6, Issue 1, 2007, Pages 36-46

Dyslipidemia in an Asian population after treatment for two years with protease inhibitor-containing regimens

Author keywords

adverse effects; Asian; dyslipidemia; highly active antiretroviral therapy; HIV; protease inhibitor

Indexed keywords

LIPID; PROTEINASE INHIBITOR;

EID: 34248563006     PISSN: 15451097     EISSN: 15570886     Source Type: Journal    
DOI: 10.1177/1545109706295946     Document Type: Article
Times cited : (10)

References (27)
  • 1
    • 0027129391 scopus 로고
    • Metabolic disturbances and wasting in the acquired immunodeficiency syndrome
    • Grunfeld C, Feingold KR. Metabolic disturbances and wasting in the acquired immunodeficiency syndrome. N Engl J Med. 1992 ; 327: 329-337.
    • (1992) N Engl J Med , vol.327 , pp. 329-337
    • Grunfeld, C.1    Feingold, K.R.2
  • 2
    • 0033583977 scopus 로고    scopus 로고
    • Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor- associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: A cohort study
    • DOI 10.1016/S0140-6736(98)08468-2
    • Carr A, Samaras K, Thorisdottir A, Kaufmann GR, Chisholm DJ, Cooper DA. Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, (Pubitemid 29278477)
    • (1999) Lancet , vol.353 , Issue.9170 , pp. 2093-2099
    • Carr, A.1    Samaras, K.2    Thorisdottir, A.3    Kaufmann, G.R.4    Chisholm, D.J.5    Cooper, D.A.6
  • 4
    • 13844255117 scopus 로고    scopus 로고
    • Impact of dyslipidemia associated with highly active antiretroviral therapy (HAART) on cardiovascular risk and life expectancy
    • DOI 10.1016/j.amjcard.2004.11.004
    • Grover SA, Coupal L, Gilmore N, Mukherjee J. Impact of dyslipidemia associated with highly active antiretroviral therapy (HAART) on cardiovascular risk and life expectancy. Am J Cardiol. 2005 ; 95: 586-591. (Pubitemid 40255245)
    • (2005) American Journal of Cardiology , vol.95 , Issue.5 , pp. 586-591
    • Grover, S.A.1    Coupal, L.2    Gilmore, N.3    Mukherjee, J.4
  • 5
    • 0034934844 scopus 로고    scopus 로고
    • Dyslipidaemia in HIV-infected patients: Association with adherence to potent antiretroviral therapy
    • DOI 10.1258/0956462011923507
    • Vergis EN, Paterson DL, Wagener MM, Swindells S, Singh N. Dyslipidaemia in HIV-infected patients: association with adherence to potent antiretroviral therapy. Int J STD AIDS. 2001 ; 12: 463-468. (Pubitemid 32656057)
    • (2001) International Journal of STD and AIDS , vol.12 , Issue.7 , pp. 463-468
    • Vergis, E.N.1    Paterson, D.L.2    Wagener, M.M.3    Swindells, S.4    Singh, N.5
  • 9
    • 0037111631 scopus 로고    scopus 로고
    • Lipodystrophy in a cohort of human immunodeficiency virus-infected asian patients: Prevalence, associated factors, and psychological impact
    • DOI 10.1086/344055
    • Paton NI, Earnest A, Ng YM, Karim F, Aboulhab J. Lipodystrophy in a cohort of human immunodeficiency virus-infected Asian patients: prevalence, associated factors, and psychological impact. Clin Infect Dis. 2002 ; 35: 1244-1249. (Pubitemid 35305873)
    • (2002) Clinical Infectious Diseases , vol.35 , Issue.10 , pp. 1244-1249
    • Paton, N.I.1    Earnest, A.2    Ng, Y.M.3    Karim, F.4    Aboulhab, J.5
  • 13
    • 0035897696 scopus 로고    scopus 로고
    • Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
    • Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001 ; 285: 2486-2497.
    • (2001) JAMA , vol.285 , pp. 2486-2497
  • 14
    • 34548307594 scopus 로고    scopus 로고
    • DAIDS. Bethesda, Md. Division of Acquired Immunodeficiency Syndrome, National Institute of Allergy and Infectious Diseases, National Institutes of Health;
    • DAIDS. Division of AIDS Table For Grading the Severity of Adult and Pediatric Adverse Events. Bethesda, Md. Division of Acquired Immunodeficiency Syndrome, National Institute of Allergy and Infectious Diseases, National Institutes of Health ; 2004.
    • (2004) Division of AIDS Table for Grading the Severity of Adult and Pediatric Adverse Events
  • 15
    • 0041524901 scopus 로고    scopus 로고
    • Indinavir did not further increase mean triglyceride levels in HIV-infected patients treated with nucleoside reverse transcriptase inhibitors: An analysis of three randomized clinical trials
    • DOI 10.1002/pds.808
    • Rojas C, Coplan PM, Rhodes T, Robertson MN, DiNubile MJ, Guess HA. Indinavir did not further increase mean triglyceride levels in HIV-infected patients treated with nucleoside reverse transcriptase inhibitors: an analysis of three randomized clinical trials. Pharmacoepidemiol Drug Saf. 2003 ; 12: 361-369. (Pubitemid 36903370)
    • (2003) Pharmacoepidemiology and Drug Safety , vol.12 , Issue.5 , pp. 361-369
    • Rojas, C.1    Coplan, P.M.2    Rhodes, T.3    Robertson, M.N.4    DiNubile, M.J.5    Guess, H.A.6
  • 16
    • 0035461510 scopus 로고    scopus 로고
    • Saquinavir and ritonavir pharmacokinetics following combined ritonavir and saquinavir (soft gelatin capsules) administration
    • Buss N, Snell P, Bock J, Hsu A, Jorga K. Saquinavir and ritonavir pharmacokinetics following combined ritonavir and saquinavir (soft gelatin capsules) administration. Br J Clin Pharmacol. 2001 ; 52: 255-264. (Pubitemid 33796222)
    • (2001) British Journal of Clinical Pharmacology, Supplement , vol.52 , Issue.3 , pp. 255-264
    • Buss, N.1    Snell, P.2    Bock, J.3    Hsu, A.4    Jorga, K.5
  • 17
    • 2042445714 scopus 로고    scopus 로고
    • Efavirenz induces a striking and generalized increase of HDL-cholesterol in HIV-infected patients
    • DOI 10.1097/00002030-200403260-00017
    • Negredo E, Ribalta J, Ferre R, et al. Efavirenz induces a striking and generalized increase of HDL-cholesterol in HIV-infected patients. AIDS. 2004 ; 18: 819-821. (Pubitemid 38535014)
    • (2004) AIDS , vol.18 , Issue.5 , pp. 819-821
    • Negredo, E.1    Ribalta, J.2    Ferre, R.3    Salazar, J.4    Rey-Joly, C.5    Sirera, G.6    Masana, L.7    Clotet, B.8
  • 18
    • 15744367156 scopus 로고    scopus 로고
    • Nevirapine and efavirenz elicit different changes in lipid profiles in antiretroviral-therapy-naive patients infected with HIV-1
    • van Leth F, Phanuphak P, Stroes E, et al. Nevirapine and efavirenz elicit different changes in lipid profiles in antiretroviral-therapy-naive patients infected with HIV-1. PLoS Med. 2004 ; 1: e19 - e19.
    • (2004) PLoS Med , vol.1
    • Van Leth, F.1    Phanuphak, P.2    Stroes, E.3
  • 20
    • 28444436183 scopus 로고    scopus 로고
    • Indinavir/ritonavir 800/100 mg bid and efavirenz 600 mg qd in patients failing treatment with combination nucleoside reverse transcriptase inhibitors: 96-week outcomes of HIV-NAT 009
    • DOI 10.1111/j.1468-1293.2005.00327.x
    • Boyd MA, Siangphoe U, Ruxrungtham K, et al. Indinavir/ritonavir 800/100 mg bid and efavirenz 600 mg qd in patients failing treatment with combination NRTIs: 96-week outcomes of HIV-NAT 009. HIV Med. 2005 ; 6: 410-420. (Pubitemid 41723309)
    • (2005) HIV Medicine , vol.6 , Issue.6 , pp. 410-420
    • Boyd, M.A.1    Siangphoe, U.2    Ruxrungtham, K.3    Duncombe, C.J.4    Stek, M.5    Lange, J.M.A.6    Cooper, D.A.7    Phanuphak, P.8
  • 22
    • 0042832397 scopus 로고    scopus 로고
    • Guidelines for the evaluation and management of dyslipidemia in human immunodeficiency virus (HIV)-infected adults receiving antiretroviral therapy: Recommendations of the HIV Medicine Association of the Infectious Disease Society of America and the Adult AIDS Clinical Trials Group
    • DOI 10.1086/378131
    • Dube MP, Stein JH, Aberg JA, et al. Guidelines for the evaluation and management of dyslipidemia in human immunodeficiency virus (HIV)-infected adults receiving antiretroviral therapy: recommendations of the HIV Medical Association of the Infectious Disease Society of America and the Adult AIDS Clinical Trials Group. Clin Infect Dis. 2003 ; 37: 613-627. (Pubitemid 37100800)
    • (2003) Clinical Infectious Diseases , vol.37 , Issue.5 , pp. 613-627
    • Dube, M.P.1    Stein, J.H.2    Aberg, J.A.3    Fichtenbaum, C.J.4    Gerber, J.G.5    Tashima, K.T.6    Henry, W.K.7    Currier, J.S.8    Sprecher, D.9    Glesby, M.J.10
  • 26
    • 19644395095 scopus 로고    scopus 로고
    • Lipodystrophy and dyslipidemia among patients taking first-line, world health organization-recommended highly active antiretroviral therapy regimens in Western India
    • Pujari SN, Dravid A, Naik E, et al. Lipodystrophy and dyslipidemia among patients taking first-line, world health organization-recommended highly active antiretroviral therapy regimens in Western India. J Acquir Immune Defic Syndr. 2005 ; 39: 199-202. (Pubitemid 40741119)
    • (2005) Journal of Acquired Immune Deficiency Syndromes , vol.39 , Issue.2 , pp. 199-202
    • Pujari, S.N.1    Dravid, A.2    Naik, E.3    Bhagat, S.4    Tash, K.5    Nadler, J.P.6    Sinnott, J.T.7


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.